(A) Western blot showing protein expression level of Yap in ATDC5 cells (n=3). (B) Quantification of Yap protein levels in (A). (C) Western blot of 10-week-old male hip cartilage from Cbfbf/f;Col2a1-CreERT mice injected with either oil or TMX showing the expression of Cbfβ, p-Smad2/3, Smad2/3, and Mmp13 (n=5). (D) Western blot of knee joint cartilage from 16-week-old male WT and Cbfbf/f;Col2a1-CreERT mice with ACLT surgery and injected with either oil or TMX showing the expression of Cbfβ (n=6). (E) Western blot of WT mice knee joint cartilage from 16-week-old male mice with ACLT surgery, treated with AAV-luc-YFP or AAV-Cbfb, and injected with either oil or TMX showing the expression of Cbfβ and active β-catenin (n=6). (F) Quantification of (C). (G) Quantification of (D). (H) Quantification of (E). Data are shown as mean ± SD. *p<0.05, **p<0.01, ***p<0.001. NS Not Significant.
Figure 8—source data 1. Labeled raw western blot data for Figure 8A (anti-Yap and anti-Gapdh).
Figure 8—source data 2. Unlabeled raw western blot data for Figure 8A (anti-Yap and anti-Gapdh).
Figure 8—source data 3. Labeled raw western blot data for Figure 8C (anti-Cbfβ, anti-p-Smad2/3, anti-Smad2/3, anti-Mmp13, and anti-Gapdh).
Figure 8—source data 4. Unlabeled raw western blot data for Figure 8C (anti-Cbfβ, anti-p-Smad2/3, anti-Smad2/3, anti-Mmp13, and anti-Gapdh).
Figure 8—source data 5. Labeled raw western blot data for Figure 8D (anti-Cbfβ and anti-Gapdh).
Figure 8—source data 6. Unlabeled raw western blot data for Figure 8D (anti-Cbfβ and anti-Gapdh).
Figure 8—source data 7. Labeled raw western blot data for Figure 8E (anti-Cbfβ, anti-active β-catenin, and anti-Gapdh).
Figure 8—source data 8. Unlabeled raw western blot data for Figure 8E (anti-Cbfβ, anti-active β-catenin, and anti-Gapdh).